NEUROGESX INC

SAN MATEO, CA How do I update this listing?

Neurogesx is based out of San Mateo. NeurogesX, Inc., a biopharmaceutical company, engages in the development and commercialization of novel pain management therapies. It primarily focuses on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP), and painful diabetic neuropathy (PDN). The company's lead product candidate NGX-4010 is a synthetic capsaicin-based topical patch to manage pain associated with peripheral neuropathic pain conditions, has completed two pivotal Phase 3 clinical trials in PHN and HIV-DSP. It is also developing NGX-1998, a non-patch liquid formulation of synthetic capsaicin, and an opioid analgesic for use in managing pain associated with other chronic pain conditions, such as cancer pain.Whalewisdom has at least 1 13G filings, and 32 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-11-27. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

neurogesx inc
2215 BRIDGEPOINTE PARKWAY
SAN MATEO CA    94404

Business Phone: 650-358-3300
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2012-11-27 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 684,300 684,300 0
2012-03-29 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 975,000 975,000 0
2012-02-08 D PHARMACEUTICALS Equity 2,999,382 2,999,382 0
2011-08-17 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 1,425,000 1,425,000 0
2011-08-03 D OTHER HEALTH CARE Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 20,209,229 20,209,229 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANTHONY A. DITONNO subscription required
    EXECUTIVE OFFICER DIRECTOR
BRADFORD S. GOODWIN subscription required
    DIRECTOR
GARY A. LYONS subscription required
    DIRECTOR
JEAN-JACQUES BIENAIME subscription required
    DIRECTOR
JEFFREY K. TOBIAS subscription required
    EXECUTIVE OFFICER
JOHN A. ORWIN subscription required
    DIRECTOR
MICHAEL E. MARKELS subscription required
    EXECUTIVE OFFICER
NEIL M. KURTZ subscription required
    DIRECTOR
ROBERT T. NELSEN subscription required
    DIRECTOR
RONALD A. MARTELL subscription required
    EXECUTIVE OFFICER DIRECTOR
STEPHEN F. GHIGLIERI subscription required
    EXECUTIVE OFFICER
STEPHEN PEROUTKA subscription required
    EXECUTIVE OFFICER
STEVEN H. NELSON subscription required
    DIRECTOR

Elevate your investments